title: The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia.
authors.affiliation: Laboratoire d'Hématologie et Unité Mixte de Recherche 7276 Centre National de la Recherche Scientifique, Centre Hospitalier Universitaire (CHU) de Limoges, Faculté de Médecine, Université de Limoges et Centre National de la Recherche Scientifique, Limoges, France;
authors.forename: Guillaume
authors.initials: G
authors.lastname: Olombel
authors.affiliation: Laboratoire d'Hématologie et Unité Mixte de Recherche 7276 Centre National de la Recherche Scientifique, Centre Hospitalier Universitaire (CHU) de Limoges, Faculté de Médecine, Université de Limoges et Centre National de la Recherche Scientifique, Limoges, France;
authors.forename: Estelle
authors.initials: E
authors.lastname: Guerin
authors.affiliation: Service d'Hématologie Biologique, CHU, Dijon, France;
authors.forename: Julien
authors.initials: J
authors.lastname: Guy
authors.affiliation: Service d'Hématologie Biologique, Hôpital Saint Antoine, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France;
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Perrot
authors.affiliation: Laboratoire d'Hématologie, CHU, Lille, France;
authors.forename: Florent
authors.initials: F
authors.lastname: Dumezy
authors.affiliation: Service d'Hématologie Adulte, Hôpital Saint-Louis, AP-HP, Université Paris Diderot, Paris, France;
authors.forename: Adrienne
authors.initials: A
authors.lastname: de Labarthe
authors.affiliation: Service d'Hématologie, CHU, Dijon, France;
authors.forename: Jean-Noël
authors.initials: JN
authors.lastname: Bastie
authors.affiliation: Service d'Hématologie, Hôtel Dieu, Hôpital Saint Antoine, AP-HP, Paris, France;
authors.forename: Ollivier
authors.initials: O
authors.lastname: Legrand
authors.affiliation: Service d'Hématologie Adulte, Hôpital Saint-Louis, AP-HP, Université Paris Diderot, Paris, France;
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Raffoux
authors.affiliation: Centre de Biologie et d'Anatomie Pathologique, Hématologie Cellulaire et Immunophénotypage des hémopathies, CHU de Lyon-Hospices Civils de Lyon, Pierre Bénite, France;
authors.forename: Adriana
authors.initials: A
authors.lastname: Plesa
authors.affiliation: Département d'Hématologie et Immunologie Biologiques, Hôpitaux universitaire Henri Mondor, AP-HP, University Paris-Est Créteil, Créteil, France;
authors.forename: Orianne
authors.initials: O
authors.lastname: Wagner-Ballon
authors.affiliation: Laboratoire d'Hématologie, CHU, Caen, France;
authors.forename: Edouard
authors.initials: E
authors.lastname: Cornet
authors.affiliation: Laboratoire d'Hématologie, CHU, Caen, France;
authors.forename: Véronique
authors.initials: V
authors.lastname: Salaun
authors.affiliation: Laboratoire d'Hématologie, CHU, Lille, France;
authors.forename: Claude
authors.initials: C
authors.lastname: Preudhomme
authors.affiliation: Service d'Hématologie, Centre Hospitalier Lyon Sud, Pierre-Bénite, France;
authors.forename: Xavier
authors.initials: X
authors.lastname: Thomas
authors.affiliation: Service d'Hématologie Clinique, Hôpital Henri Mondor, AP-HP, Créteil, France;
authors.forename: Cécile
authors.initials: C
authors.lastname: Pautas
authors.affiliation: Service d'Hématologie, CHU, Caen, France;
authors.forename: Sylvain
authors.initials: S
authors.lastname: Chantepie
authors.affiliation: Service d'Hématologie, CHU, Limoges, France; and.
authors.forename: Pascal
authors.initials: P
authors.lastname: Turlure
authors.affiliation: Service d'Hématologie-Oncologie, Centre Hospitalier, Versailles, France.
authors.forename: Sylvie
authors.initials: S
authors.lastname: Castaigne
authors.affiliation: Service d'Hématologie Adulte, Hôpital Saint-Louis, AP-HP, Université Paris Diderot, Paris, France;
authors.forename: Hervé
authors.initials: H
authors.lastname: Dombret
authors.affiliation: Laboratoire d'Hématologie et Unité Mixte de Recherche 7276 Centre National de la Recherche Scientifique, Centre Hospitalier Universitaire (CHU) de Limoges, Faculté de Médecine, Université de Limoges et Centre National de la Recherche Scientifique, Limoges, France;
authors.forename: Jean
authors.initials: J
authors.lastname: Feuillard
mesh_terms: D000368:Aged; D000617:Aminoglycosides / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000074322:Antineoplastic Agents, Immunological / Q000627:therapeutic use*; D005260:Female; D000079982:Gemtuzumab; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D063268:Sialic Acid Binding Ig-like Lectin 3 / Q000032:analysis*; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000617:Aminoglycosides; D061067:Antibodies, Monoclonal, Humanized; D000074322:Antineoplastic Agents, Immunological; D063268:Sialic Acid Binding Ig-like Lectin 3; D000079982:Gemtuzumab